Literature DB >> 33427415

Kv1.1 potassium channel subunit deficiency alters ventricular arrhythmia susceptibility, contractility, and repolarization.

Krystle Trosclair1, Man Si1, Megan Watts2, Nicole M Gautier1, Niels Voigt3,4, James Traylor5, Miklós Bitay6, Istvan Baczko7, Dobromir Dobrev8, Kathryn A Hamilton1, Md Shenuarin Bhuiyan5, Paari Dominic2, Edward Glasscock1,9.   

Abstract

Epilepsy-associated Kv1.1 voltage-gated potassium channel subunits encoded by the Kcna1 gene have traditionally been considered absent in heart, but recent studies reveal they are expressed in cardiomyocytes where they could regulate intrinsic cardiac electrophysiology. Although Kv1.1 now has a demonstrated functional role in atria, its role in the ventricles has never been investigated. In this work, electrophysiological, histological, and gene expression approaches were used to explore the consequences of Kv1.1 deficiency in the ventricles of Kcna1 knockout (KO) mice at the organ, cellular, and molecular levels to determine whether the absence of Kv1.1 leads to ventricular dysfunction that increases the risk of premature or sudden death. When subjected to intracardiac pacing, KO mice showed normal baseline susceptibility to inducible ventricular arrhythmias (VA) but resistance to VA under conditions of sympathetic challenge with isoproterenol. Echocardiography revealed cardiac contractile dysfunction manifesting as decreased ejection fraction and fractional shortening. In whole-cell patch-clamp recordings, KO ventricular cardiomyocytes exhibited action potential prolongation indicative of impaired repolarization. Imaging, histological, and transcript analyses showed no evidence of structural or channel gene expression remodeling, suggesting that the observed deficits are likely electrogenic due to Kv1.1 deficiency. Immunoblots of patient heart samples detected the presence of Kv1.1 at relatively high levels, implying that Kv1.1 contributes to human cardiac electrophysiology. Taken together, this work describes an important functional role for Kv1.1 in ventricles where its absence causes repolarization and contractility deficits but reduced susceptibility to arrhythmia under conditions of sympathetic drive.
© 2021 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society.

Entities:  

Keywords:  K-channel; action potential; arrhythmia; contractility; repolarization

Mesh:

Substances:

Year:  2021        PMID: 33427415      PMCID: PMC7798052          DOI: 10.14814/phy2.14702

Source DB:  PubMed          Journal:  Physiol Rep        ISSN: 2051-817X


  33 in total

1.  Kv1.1 potassium channel deficiency reveals brain-driven cardiac dysfunction as a candidate mechanism for sudden unexplained death in epilepsy.

Authors:  Edward Glasscock; Jong W Yoo; Tim T Chen; Tara L Klassen; Jeffrey L Noebels
Journal:  J Neurosci       Date:  2010-04-14       Impact factor: 6.167

Review 2.  Genetics of cardiac arrhythmias.

Authors:  Arthur A M Wilde; Connie R Bezzina
Journal:  Heart       Date:  2005-10       Impact factor: 5.994

3.  Cardiac fibrosis as a determinant of ventricular tachyarrhythmias.

Authors:  Norishige Morita; William J Mandel; Yoshinori Kobayashi; Hrayr S Karagueuzian
Journal:  J Arrhythm       Date:  2014-12-01

4.  Deletion of the K(V)1.1 potassium channel causes epilepsy in mice.

Authors:  S L Smart; V Lopantsev; C L Zhang; C A Robbins; H Wang; S Y Chiu; P A Schwartzkroin; A Messing; B L Tempel
Journal:  Neuron       Date:  1998-04       Impact factor: 17.173

5.  Genetic ablation or pharmacological inhibition of Kv1.1 potassium channel subunits impairs atrial repolarization in mice.

Authors:  Man Si; Krystle Trosclair; Kathryn A Hamilton; Edward Glasscock
Journal:  Am J Physiol Cell Physiol       Date:  2018-11-14       Impact factor: 4.249

Review 6.  Genetics of long-QT syndrome.

Authors:  Yukiko Nakano; Wataru Shimizu
Journal:  J Hum Genet       Date:  2015-06-25       Impact factor: 3.172

Review 7.  Mechanisms of sudden unexplained death in epilepsy.

Authors:  Alica M Goldman
Journal:  Curr Opin Neurol       Date:  2015-04       Impact factor: 5.710

8.  Sudden unexpected death in epilepsy genetics: Molecular diagnostics and prevention.

Authors:  Alica M Goldman; Elijah R Behr; Christopher Semsarian; Richard D Bagnall; Sanjay Sisodiya; Paul N Cooper
Journal:  Epilepsia       Date:  2016-01       Impact factor: 5.864

9.  Neuron-specific Kv1.1 deficiency is sufficient to cause epilepsy, premature death, and cardiorespiratory dysregulation.

Authors:  Krystle Trosclair; Hemangini A Dhaibar; Nicole M Gautier; Vikas Mishra; Edward Glasscock
Journal:  Neurobiol Dis       Date:  2020-01-21       Impact factor: 5.996

10.  Doxorubicin-induced cardiomyopathy associated with inhibition of autophagic degradation process and defects in mitochondrial respiration.

Authors:  Chowdhury S Abdullah; Shafiul Alam; Richa Aishwarya; Sumitra Miriyala; Mohammad Alfrad Nobel Bhuiyan; Manikandan Panchatcharam; Christopher B Pattillo; A Wayne Orr; Junichi Sadoshima; Joseph A Hill; Md Shenuarin Bhuiyan
Journal:  Sci Rep       Date:  2019-02-14       Impact factor: 4.379

View more
  3 in total

1.  Kv1.1 potassium channel subunit deficiency alters ventricular arrhythmia susceptibility, contractility, and repolarization.

Authors:  Krystle Trosclair; Man Si; Megan Watts; Nicole M Gautier; Niels Voigt; James Traylor; Miklós Bitay; Istvan Baczko; Dobromir Dobrev; Kathryn A Hamilton; Md Shenuarin Bhuiyan; Paari Dominic; Edward Glasscock
Journal:  Physiol Rep       Date:  2021-01

Review 2.  The role of astrocytes in epileptic disorders.

Authors:  Parichehr Hayatdavoudi; Mahmoud Hosseini; Vahid Hajali; Azar Hosseini; Arezoo Rajabian
Journal:  Physiol Rep       Date:  2022-03

Review 3.  The brain-heart interaction in epilepsy: implications for diagnosis, therapy, and SUDEP prevention.

Authors:  Giorgio Costagliola; Alessandro Orsini; Monica Coll; Ramon Brugada; Pasquale Parisi; Pasquale Striano
Journal:  Ann Clin Transl Neurol       Date:  2021-05-28       Impact factor: 4.511

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.